The Asia Pacific Laser BPH Devices Market would witness market growth of 6.3% CAGR during the forecast period (2022-2028).
Various scans are performed to see the shape and size of the prostate. Some BPH scans include ultrasounds, which look inside the patient's body and know the prostate's shape and size. Cystoscopy looks at the urethra or bladder with a scope. Computing tomography (CT) and Magnetic resonance imaging (MRI) and are more detailed scans. These are done when surgery is necessary to reopen the urine flow. These scans provide a clear image of the prostate and surrounding area while showcasing the precise location and size of the enlarged prostate.
Prostate-specific antigen (PSA) blood tests are utilized to screen for prostate cancer. The PSA blood test checks the PSA level, a protein made only by the prostate gland. This blood test can be performed in a lab, provider’s office, or hospital. Very little PSA is found in the blood when the prostate is healthy. A fast rise in the PSA may be a sign of an illness. A benign (non-cancer) prostate enlargement can cause a rise in PSA levels, as can the inflammation of the prostate.
In the recent report of the Indian Council of Medical Research, which was conducted in four different zones of urban and rural India. The study report showcased that the prevalence of prediabetes and diabetes was higher in the regions compared to the previously performed studies. Furthermore, in 2012, a survey carried out by the National Nutrition Monitoring Bureau in the rural population showed that around 8.2% of adult men had diabetes. The cases were reported to be higher in the states like Tamil Nadu, Gujrat, and Kerala, which ranged from 8.2 – 16.4%.
The China market dominated the Asia Pacific Laser BPH Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $46.8 Million by 2028. The Japan market is estimated to grow a CAGR of 5.7% during (2022 - 2028). Additionally, The India market would display a CAGR of 7% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Clinics and Others. Based on Procedure, the market is segmented into Photoselective Vaporization of Prostate and Holium Laser Ablation. Based on Type, the market is segmented into Holmium Laser, Thulium Laser, Green Light Laser and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Laser BPH Devices Market is Projected to reach USD 619.9 Billion by 2028, at a CAGR of 5.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, OmniGuide, Inc., Richard Wolf GmbH, Coloplast Group, Agiliti, Inc., HealthTronics, Inc. (Altaris Capital Partners, LLC), Endo International PLC, Teleflex, Inc., Biolitec AG, and Metrum Cryoflex Sp. z o.o.
By End User
By Procedure
By Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
